Clinical Trials
6 trialsNCT01703520 2024-05-10
2003.021
Organon and Co
Completed
NCT01570036 2020-12-02
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Cancer Insight, LLC
Phase 2 Completed
NCT02580448 2019-02-01
CLARITY-01
Innocrin Pharmaceutical
Phase 1/2 Completed
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed
NCT00006370 2013-05-01
Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
Novartis
Phase 2 Completed
NCT00106002 2009-06-01
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Eli Lilly and Company
Phase 2 Completed